Back
Aligos Therapeutics, Inc. 10K Form
Buy
78
ALGS
Aligos Therapeutics, Inc.
Last Price:
$10.70
Seasonality Move:
-0.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALGS News And Ratings
See the #1 stock for the next 7 days that we like better than ALGS
ALGS Financial Statistics
Sales & Book Value
| Annual Sales: | $3.9M |
|---|---|
| Cash Flow: | $-24.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $11.67 |
| Price / Book: | 0.86 |
Profitability
| EPS (TTM): | -19.76400 |
|---|---|
| Net Income (TTM): | $-86.5M |
| Gross Margin: | $1.3M |
| Return on Equity: | -138.89% |
| Return on Assets: | -77.83% |
Aligos Therapeutics, Inc. Earnings Forecast
Key Aligos Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for ALGS is 33.54%.
-
The Selling, General & Administrative Expenses for ALGS have been equal to 578.71% of Gross Profit Margin.
-
The Research & Development expenses have been 1,781.22% of Revenue.
-
The Net Earning history of ALGS is -3,326.01% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 1 years.
Aligos Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALGS |
| Website: | aligos.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 4.7 |
| Quick Ratio: | 4.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ALGS Technical Analysis vs Fundamental Analysis
Buy
78
Aligos Therapeutics, Inc. (ALGS)
is a Buy
Is Aligos Therapeutics, Inc. a Buy or a Sell?
-
Aligos Therapeutics, Inc. stock is rated a BuyThe current Aligos Therapeutics, Inc. [ALGS] share price is $9.99. The Score for ALGS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.